Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Por Miners, John O, Birkett, Donald J
Publicado em 1998

Serum Alkaline Phosphatase in Pregnancy: an Immunological Study

Por Birkett, Donald J., Done, James, Neale, Francis C., Posen, Solomon
Publicado em 1966

Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia

Por McManus, Peter, Marley, John, Birkett, Donald J, Lindner, Julie
Publicado em 1998

Nonspecific binding of drugs to human liver microsomes

Por McLure, James A, Miners, John O, Birkett, Donald J
Publicado em 2000

Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo

Por TASSANEEYAKUL, WICHITTRA, BIRKETT, DONALD J., PASS, MICHAEL C., MINERS, JOHN O.
Publicado em 1996

The xenobiotic inhibitor profile of cytochrome P4502C8

Por Ong, Chin-Eng, Coulter, Sally, Birkett, Donald J, Bhasker, C Ramana, Miners, John O
Publicado em 2000

A Quantitative Comparison of Anti-HIV Gene Therapy Delivered to Hematopoietic Stem Cells versus CD4+ T Cells

Por Savkovic, Borislav, Nichols, James, Birkett, Donald, Applegate, Tanya, Ledger, Scott, Symonds, Geoff, Murray, John M.
Publicado em 2014

In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy

Por Applegate, Tanya Lynn, Birkett, Donald John, Mcintyre, Glen John, Jaramillo, Angel Belisario, Symonds, Geoff, Murray, John Michael
Publicado em 2010

Identification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide elimination

Por Elliot, David J, Suharjono, Lewis, Benjamin C, Gillam, Elizabeth M J, Birkett, Donald J, Gross, Annette S, Miners, John O
Publicado em 2007

Interfering ribonucleic acids that suppress expression of multiple unrelated genes

Por Passioura, Toby, Gozar, Mary M, Goodchild, Amber, King, Andrew, Arndt, Greg M, Poidinger, Michael, Birkett, Donald J, Rivory, Laurent P
Publicado em 2009